These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9625857)

  • 1. Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatin.
    Raaphorst GP; Maio J; Ng CE; Stewart DJ
    Oncol Rep; 1998; 5(4):971-7. PubMed ID: 9625857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin and mild hyperthermia in radiosensitization to low dose rate irradiation in human ovarian carcinoma cells.
    Raaphorst GP; Miao J; Ng CE
    Anticancer Res; 1997; 17(5A):3469-72. PubMed ID: 9413189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of mild hyperthermia, cisplatin and split dose irradiation in human ovarian carcinoma cells.
    Raaphorst GP; Miao J; Stewart D; Ng CE
    Cancer Chemother Pharmacol; 1998; 41(6):491-6. PubMed ID: 9554594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to pulsed dose rate irradiation with and without mild hyperthermia using tumour and normal cell lines.
    Niedbala M; Ng CE; Raaphorst GP
    Int J Hyperthermia; 2001; 17(6):536-44. PubMed ID: 11719969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines.
    Raaphorst GP; Yang H; Wilkins DE; Ng CE
    Int J Hyperthermia; 1996; 12(6):801-12. PubMed ID: 8950160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment.
    Raaphorst GP; Wang G; Stewart D; Ng CE
    Int J Radiat Biol; 1996 May; 69(5):623-31. PubMed ID: 8648250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of hyperthermia cisplatin sensitization in human ovarian carcinoma and glioma cell lines sensitive and resistant to cisplatin treatment.
    Raaphorst GP; Doja S; Davis L; Stewart D; Ng CE
    Cancer Chemother Pharmacol; 1996; 37(6):574-80. PubMed ID: 8612312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cisplatin treatment given concurrently with pulsed irradiation in cisplatin sensitive and resistant human ovarian carcinoma cell lines.
    Leblanc JM; Raaphorst P
    Int J Radiat Biol; 2005 Jun; 81(6):429-35. PubMed ID: 16308913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment.
    Raaphorst GP; Chabot P; Doja S; Wilkins D; Stewart D; Ng CE
    Int J Hyperthermia; 1996; 12(2):211-22. PubMed ID: 8926390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and low dose rate irradiation in cisplatin resistant and sensitive human glioma cells.
    Wilkins DE; Ng CE; Raaphorst GP
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):105-11. PubMed ID: 8823265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle perturbations in cisplatin-sensitive and resistant human ovarian carcinoma cells following treatment with cisplatin and low dose rate irradiation.
    Wilkins DE; Ng CE; Raaphorst GP
    Cancer Chemother Pharmacol; 1997; 40(2):159-66. PubMed ID: 9182838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
    Chen G; Zeller WJ; Todorov DK
    Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between low dose-rate irradiation, mild hyperthermia and low-dose caffeine in a human lung cancer cell line.
    Sakurai H; Mitsuhashi N; Tamaki Y; Akimoto T; Murata O; Kitamoto Y; Maebayashi K; Ishikawa H; Hayakawa K; Niibe H
    Int J Radiat Biol; 1999 Jun; 75(6):739-45. PubMed ID: 10405004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatin.
    Raaphorst GP; Mao J; Yang H; Goel R; Niknafs B; Shirazi FH; Yazdi HM; Rippstein P; Ng CE
    Anticancer Res; 1998; 18(4C):2945-51. PubMed ID: 9713489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
    Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
    Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cross-resistance between responses to cisplatin, hyperthermia, and radiation in human glioma cells and eight clones selected for cisplatin resistance.
    Raaphorst GP; Wilkins DE; Mao JP; Miao JC; Ng CE
    Radiat Oncol Investig; 1999; 7(3):153-7. PubMed ID: 10406056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic enhancement of low dose-rate irradiation in human lung cancer cells by mild hyperthermia.
    Sakurai H; Mitsuhashi N; Kitamoto Y; Nonaka T; Harashima K; Higuchi K; Muramatsu H; Ebara T; Ishikawa H; Niibe H
    Anticancer Res; 1998; 18(4A):2525-8. PubMed ID: 9703904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalence of pulsed-dose-rate to low-dose-rate irradiation in tumor and normal cell lines.
    Niedbala M; Alsbeih G; Ng CE; Raaphorst GP
    Radiat Res; 2001 Feb; 155(2):297-303. PubMed ID: 11175664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
    Caney C; Singh G; Lukka H; Rainbow AJ
    Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal radiosensitization by 41 degrees C hyperthermia during low dose-rate irradiation in human normal and tumour cell lines.
    Raaphorst GP; Heller DP; Bussey A; Ng CE
    Int J Hyperthermia; 1994; 10(2):263-70. PubMed ID: 8064184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.